Advanced Biomed Inc
NASDAQ:ADVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Advanced Biomed Inc
Total Current Liabilities
Advanced Biomed Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Advanced Biomed Inc
NASDAQ:ADVB
|
Total Current Liabilities
$2.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Total Current Liabilities
$2.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Total Current Liabilities
$2.8B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
5%
|
|
|
CareDx Inc
NASDAQ:CDNA
|
Total Current Liabilities
$89.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
24%
|
|
|
Veracyte Inc
NASDAQ:VCYT
|
Total Current Liabilities
$59.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
29%
|
CAGR 10-Years
15%
|
|
|
Neogenomics Inc
NASDAQ:NEO
|
Total Current Liabilities
$88.3m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
Advanced Biomed Inc
Glance View
Advanced Biomed Inc is a US-based company operating in industry. The company is headquartered in Reno, Nevada and currently employs 40 full-time employees. The company went IPO on 2025-03-06. Advanced Biomed Inc. is a holding company that operates, through its subsidiaries, Advanced Biomed Inc. (Taiwan) and Advanced Biomed HK Limited. The firm is engaged in the provision of assay products and services for cancer patients. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. The company has developed a microfluidic technology platform to integrate research and development, design, and manufacture of biochips and microfluidic chips. The platform combines its patented chip technology and will enable localized operations of a variety of microfluidic chips, biosensors made by semiconductor fabrication technology, and integrated application patented technology. The firm offers devices, such as A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre-Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip.
See Also
What is Advanced Biomed Inc's Total Current Liabilities?
Total Current Liabilities
2.9m
USD
Based on the financial report for Jun 30, 2025, Advanced Biomed Inc's Total Current Liabilities amounts to 2.9m USD.
What is Advanced Biomed Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
-1%
Over the last year, the Total Current Liabilities growth was 6%. The average annual Total Current Liabilities growth rates for Advanced Biomed Inc have been -1% over the past three years .
